EUVIMEDEUVIMED entdecken
Crossref

Novel, tightly structurally related N-myristoyltransferase inhibitors display equally potent yet distinct inhibitory mechanisms

Frédéric Rivière, Cyril Dian, Rémi F Dutheil, Paul Monassa, Carmela Giglione, Thierry Meinnel

Structure · 2024

DOI: 10.1016/j.str.2024.08.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2024. Verfasst von Frédéric Rivière und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France. Hauptthemen laut MEDLINE: Acyltransferases, Enzyme Inhibitors, Catalytic Domain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-myristoyltransferases (NMTs) catalyze essential acylations of N-terminal alpha or epsilon amino groups of glycines or lysines. Here, we reveal that peptides tightly fitting the optimal glycine recognition pattern of human NMTs are potent prodrugs relying on a single-turnover mechanism. Sequence scanning of the inhibitory potency of the series closely reflects NMT glycine substrate specificity rules, with the lead inhibitor blocking myristoylation by NMTs of various species. We further redesigned the series based on the recently recognized lysine-myristoylation mechanism by taking advantage of (1) the optimal peptide chassis and (2) lysine side chain mimicry with unnatural enantiomers. Unlike the lead series, the inhibitory properties of the new compounds rely on the protonated state of the side chain amine, which stabilizes a salt bridge with the catalytic base at the active site. Our study provides the basis for designing first-in-class NMT inhibitors tailored for infectious diseases and alternative active site targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcyltransferasesEnzyme InhibitorsCatalytic DomainHumansSubstrate SpecificityModels, MolecularGlycineLysineProtein BindingPeptides

Stichwörter der Autor:innen

N-myristoyltransferaseN-terminal modificationacylationcatalysisenzyme inhibitionlysinemyristoylationsalt bridge

Substanzen

AcyltransferasesEnzyme Inhibitorsglycylpeptide N-tetradecanoyltransferaseGlycineLysinePeptides

Autor:innen und Institutionen

  • Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.
  • Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France. Electronic address: carmela.giglione@i2bc.paris-saclay.fr.
  • Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France. Electronic address: thierry.meinnel@i2bc.paris-saclay.fr.

Zitieren

APA

Rivière, F., Dian, C., Dutheil, R. F., Monassa, P., Giglione, C., & Meinnel, T. (2024). Novel, tightly structurally related N-myristoyltransferase inhibitors display equally potent yet distinct inhibitory mechanisms. Structure. https://doi.org/10.1016/j.str.2024.08.001

Vancouver

Rivière F, Dian C, Dutheil RF, Monassa P, Giglione C, Meinnel T. Novel, tightly structurally related N-myristoyltransferase inhibitors display equally potent yet distinct inhibitory mechanisms. Structure. 2024. doi:10.1016/j.str.2024.08.001

BibTeX
@article{Rivire2024,
  author = {Rivière, Frédéric and Dian, Cyril and Dutheil, Rémi F and Monassa, Paul and Giglione, Carmela and Meinnel, Thierry},
  title = {Novel, tightly structurally related N-myristoyltransferase inhibitors display equally potent yet distinct inhibitory mechanisms},
  journal = {Structure},
  year = {2024},
  doi = {10.1016/j.str.2024.08.001}
}
Kostenlos starten →